Amicus Therapeutics, Inc. (NASDAQ:FOLD) will hold its 3Q20 earnings conference call with the financial community on 5th November 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.amicusrx.com
Earnings Expectation
Amicus Therapeutics, Inc. is set to announce third quarter earning results on Thursday 5th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, FOLD to report 3Q20 loss of $ 0.22 per share. For the full year, analysts anticipate top line of $ 256.88 million, while looking forward to loss of $ 1 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 250.00 million ~ $ 260.00 million
Click Here For More Historical Outlooks Of Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting a Phase 1/2 clinical study of ATB200-02 for indications, including pompe disease.
